Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0140-6736(89)90204-3 | DOI Listing |
Folia Med Cracov
April 2023
Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland.
Atopic dermatitis (AD) is the most common inflammatory skin disease. However, recent reports concerning the simple clinical aspects of treatment with topical glucocorticosteroids (TCS) and calcineurin inhibitors (TCI) are lacking. The objective of this study is providing an update on these characteristics of AD management.
View Article and Find Full Text PDFJ Clin Med
September 2022
Department of Paediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia.
Intravenous cannulation is experientially traumatic to children. To minimize this, EMLA is applied on the would-be-cannulated area before IV cannula insertion. However, the time to achieve its maximum efficacy may be affected due to incomplete cutaneous absorption and the duration of application.
View Article and Find Full Text PDFJ Am Acad Dermatol
February 2022
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. Electronic address:
Background: Facial involvement of vitiligo is an important factor in a patient's life and has often been evaluated separately from body surface area in clinical trials. However, no reliable tools to measure facial vitiligo specifically are available thus far.
Objective: To develop and validate a practical instrument for assessing facial vitiligo.
J Dermatol
September 2021
Department of Nephrology, Nippon Medical School, Bunkyo-ku, Japan.
Xerosis and pruritus are common in patients undergoing dialysis. These symptoms are treated with moisturizers, but limited evidence supports the efficacy of such treatment. Our exploratory study suggested the effectiveness of a heparinoid-containing product for xerosis in dialysis patients.
View Article and Find Full Text PDFAm Fam Physician
March 2021
Mayo Clinic Family Medicine Residency Program, La Crosse, WI, USA.
Topical corticosteroids are an essential tool for treating inflammatory skin conditions such as psoriasis and atopic dermatitis. Topical corticosteroids are classified by strength and the risk of adverse effects such as atrophy, striae, rosacea, telangiectasias, purpura, and other cutaneous and systemic reactions. The risk of adverse effects increases with prolonged use, a large area of application, higher potency, occlusion, and application to areas of thinner skin such as the face and genitals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!